A Study of Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer Participants Who Responded Poorly to the First-line Combined Androgen Blockade Therapy
Clinical trial NCT02405858 · COMPLETED
Trial details
- NCT number
- NCT02405858
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-10
- Primary completion
- 2017-12-31
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.